{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Plitidepsin",
  "nciThesaurus": {
    "casRegistry": "137219-37-5",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin displays a broad spectrum of antitumor activities, inducing apoptosis by triggering mitochondrial cytochrome c release, initiating the Fas/DC95, JNK pathway and activating caspase 3 activation. This agent also inhibits elongation factor 1-a, thereby interfering with protein synthesis, and induces G1 arrest and G2 blockade, thereby inhibiting tumor cell growth.",
    "fdaUniiCode": "Y76ID234HW",
    "identifier": "C1689",
    "preferredName": "Plitidepsin",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C1976",
      "C784"
    ],
    "synonyms": [
      "APLD",
      "Aplidin",
      "Aplidine",
      "DDB",
      "Dehydrodemnin B",
      "Dehydrodidemnin B",
      "N-[1-(1,2-Dioxopropyl)-L-prolyl]didemnin A",
      "PLITIDEPSIN",
      "Plitidepsin",
      "aplidine"
    ]
  }
}